Keyphrases
Older Adults
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Standard of Care
100%
Older Patients
100%
Reduced-intensity Conditioning
100%
Clinical Trials
25%
Graft-versus-host Disease (GvHD)
25%
Improved Outcomes
25%
Transplant Recipients
25%
Regulatory T Cells
25%
Transplantation
25%
Hematopoietic Cell Transplantation
25%
Comorbidity
25%
Patient Characteristics
25%
Transplant Outcomes
25%
Natural Killer Cell Immunotherapy
25%
Disease Pattern
25%
Reduced Intensity
25%
Chemotherapy Alone
25%
Transplantation Conditioning
25%
Overall Survival Rate
25%
Transplant-related Mortality
25%
Conditioning Intensity
25%
Reduced Intensity Transplantation
25%
Complicating Factors
25%
Mortality Outcomes
25%
Myeloablative Regimen
25%
T-cell Modulation
25%
Selected Populations
25%
Biochemistry, Genetics and Molecular Biology
Allogeneic Stem Cell Transplantation
100%
Conditioning
100%
Clinical Trial
50%
Prospective Study
50%
Host
50%
Cell Transplantation
50%
Overall Survival
50%
Survival Rate
50%
Regulatory T Cell
50%
Natural Killer Cell
50%
Comorbidity
50%
Hematopoietic Cell
50%
Medicine and Dentistry
Transplantation
100%
Allogeneic Stem Cell Transplantation
100%
Reduced Intensity Conditioning
100%
Disease
25%
Chemotherapy
25%
Prospective Study
25%
Clinical Trial
25%
Hematopoietic Cell
25%
Cell Transplantation
25%
Regulatory T Cell
25%
Conditioning
25%
Overall Survival
25%
Survival Rate
25%
Graft Versus Host Reaction
25%
Natural Killer Cell
25%
Immunotherapy
25%
Comorbidity
25%
Nursing and Health Professions
Health Care Quality
100%
Transplantation
100%
Reduced Intensity Conditioning
100%
Allogeneic Stem Cell Transplantation
100%
Immunotherapy
25%
Survival Rate
25%
Cell Transplantation
25%
Overall Survival
25%
Disease
25%
Graft Versus Host Reaction
25%
Comorbidity
25%